Synthetic Minds | The Brain’s Save Button

Jan 29, 2026

👋 Hi, I am Mark. I am a strategic futurist and innovation keynote speaker. I advise governments and enterprises on emerging technologies such as AI or the metaverse. My subscribers receive a free weekly newsletter on cutting-edge technology.

The Synthetic Minds newsletter is evolving. Short daily insights to get you thinking. If you enjoy it, please forward. If you need more insights, subscribe to Futurwise and get 25% off for the first three months!

The Brain’s Save Button Forces a Healthcare Pivot

For 30 years, we’ve treated amyloids like garbage and built a billion-dollar “cleanup” industry around them. Then the researchers found a chaperone protein they named Funes that controls when a memory protein assembles into a functional amyloid, turning long-term memory formation on or off in living models. That’s not plaque; that’s biology using a precision tool.

This is where AI collides with biology in a way boards and insurers can’t ignore: the competitive edge shifts from destructive neuro-medicine (clear everything) to constructive chaperone therapy (guide assembly, preserve function).

AI can increasingly predict molecular interactions and accelerate engineered biology, making “programming protein states” a plausible R&D direction rather than sci-fi.

Insurance is the silent kingmaker here. If you keep paying for late-stage rescue, you’ll keep getting late-stage rescue outcomes.

However, if you underwrite prevention-first “biological asset management,” you pull the whole system toward preserving what’s healthy, using the body’s own mechanisms to prevent decline. And along the way, you will save society trillions of dollars.

So who will fund the switch from clearing brains to stabilizing minds?

'Synthetic Minds' continues to reflect the synthetic forces reshaping our world. Quick, curated insights to feed your quest for a better understanding of our evolving synthetic future, powered by Futurwise:

1. Microsoft has introduced Maia 200, a breakthrough AI inference accelerator designed to improve the economics of AI token generation. (Microsoft)

2. The Technology Innovation Institute is advocating for a shift in focus towards building trusted systems in deep tech, rather than just individual breakthroughs. System-level thinking is the key to trust in deep tech. (Quantum Zeitgeist)

3. Researchers designed a virus, named Evo-Φ2147, entirely by AI and assembled it from scratch in a laboratory, marking a significant milestone in synthetic life. This achievement raises profound questions about the intersection of biotechnology, governance, and human restraint. (The Blogging Hounds)

4. Researchers have developed a new method to identify and monitor small mammals by analyzing their footprints with AI, achieving accuracy rates of up to 96% in distinguishing between two nearly indistinguishable species of sengi. (ScienceDaily)

5. Blockchain technology is set to face a maturity test in 2026, where its real-world viability will be assessed, although blockchain replacing existing systems is still some time away. (PYMNTS)

If you are interested in more insights, grab my latest, award-winning, book Now What? How to Ride the Tsunami of Change and learn how to embrace a mindset that can deal with exponential change, or download my news 2026 tech trends report:

If this newsletter was forwarded to you, you can sign up here.

Thank you.
Mark

Frequently asked questions

What is the chaperone protein Funes and why does it matter?

Funes is a chaperone protein that researchers found controls when a memory protein assembles into a functional amyloid, turning long-term memory formation on or off in living models. This matters because it reframes amyloids not simply as garbage to clean up, but as part of a precision biological tool that regulates memory, opening a new therapeutic direction focused on guiding assembly rather than destroying it.

Link to this question

How does this discovery change the approach to neuro-medicine?

For decades, treatment centered on destructive neuro-medicine that aimed to clear amyloids entirely, spawning a billion-dollar cleanup industry. The discovery of a chaperone that guides functional amyloid assembly shifts the competitive edge toward constructive chaperone therapy, which guides assembly and preserves function instead of destroying it, using the body's own mechanisms to prevent decline rather than rescuing it after damage.

Link to this question

What role does AI play in this healthcare shift?

AI increasingly can predict molecular interactions and accelerate engineered biology, making the idea of programming protein states a plausible research and development direction rather than science fiction. This capability helps enable the shift from destructive amyloid-clearing approaches toward constructive chaperone therapies that guide protein assembly to preserve healthy brain function.

Link to this question

Why is insurance described as the key factor in adopting this treatment approach?

Insurance is called the silent kingmaker because payment models determine which outcomes the healthcare system produces. If insurers keep paying only for late-stage rescue treatments, late-stage rescue outcomes will keep resulting. But if insurers underwrite prevention-first biological asset management, the system would shift toward preserving health using the body's own mechanisms, potentially saving society trillions of dollars.

Link to this question